Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.

Rowland, Rosalind; Pathan, Ansar A; Satti, Iman; Poulton, Ian D; Matsumiya, Magali ML; Whittaker, Megan; Minassian, Angela M; O'Hara, Geraldine A; Hamill, Matthew; Scott, Janet T; +9 more... Harris, Stephanie A; Poyntz, Hazel C; Bateman, Cynthia; Meyer, Joel; Williams, Nicola; Gilbert, Sarah C; Lawrie, Alison M; Hill, Adrian VS; McShane, Helen; (2013) Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial. Human vaccines & immunotherapeutics, 9 (1). pp. 50-62. ISSN 2164-5515 DOI: https://doi.org/10.4161/hv.22464

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.4161/hv.22464

Abstract

Share

Download

Filename: hvi-9-50.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar